CLASS ACTION LAWSUIT HOME PAGE
If You Paid for
PROVIGIL®
or Generic Versions of Provigil® (Modafinil)
You Could Get Money from a
Class Action Settlement
Settlements have been reached in a class action lawsuit
regarding the price that consumers and third-party payors paid for
Provigil® and generic versions of Provigil® (Modafinil).
You may be able to recover money if
you are a consumer or a third-party payor
who paid for or reimbursed all or part of the cost
of Provigil® or Modafinil in certain states
during the period from June 24, 2006 through August 8, 2019.
UPDATE
The Court held the Final Approval Hearing on February 26, 2020 at the United States District Court for the Eastern District of Pennsylvania.
On April 21, 2020, the Court entered an order approving the settlements, fees, expenses and incentive awards. The Final Approval Order and
accompanying Memorandum Opinion are available on the Court Documents page of this website.
The Settlement Administrator is continuing to process claim forms. Claimants that provided deficient claim forms and/or require additional
information to substantiate their claims will be notified in the upcoming weeks. Please note that all claims must be finalized prior to
distribution. If you have any questions about your claim or the claim process please contact the Settlement Administrator by email at info@ProvigilSettlement.com or call 1-877-241-7503.
The lawsuit asserts that Defendants Cephalon, Inc., Teva Pharmaceutical Industries, Ltd.,
Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals, Inc. (collectively, “Cephalon”), Mylan
Pharmaceuticals Inc. and Mylan, Inc. (formerly known as Mylan Laboratories, Inc.)
(collectively, “Mylan”), and Sun Pharmaceuticals Industries, Ltd., as successor in interest to
Ranbaxy Laboratories, Ltd. and Ranbaxy Pharmaceuticals, Inc., (collectively “Ranbaxy”)
violated state antitrust and consumer protection laws relating to the sale of the prescription
pharmaceutical Provigil. All Defendants have denied any wrongdoing.
A $48,000,000 Settlement has been reached between the End-Payor Class Plaintiffs
(consumers and third-party payors) and the Cephalon Defendants, a $14,377,600
Settlement with the Mylan Defendants, and a $3,500,000 Settlement with the Ranbaxy
Defendants. The three Settlements total $65,877,600.
| Your Legal Rights and Options in These Settlements | ||
|---|---|---|
| FILE A CLAIM | This is the only way to receive money from the Settlements | January 15, 2020 |
| EXCLUDE YOURSELF | You will receive no benefits, but you will retain any rights you currently have to sue the Cephalon, Mylan and Ranbaxy Defendants about the claims in this case. | December 6, 2019 |
| OBJECT TO THE SETTLEMENTS | Write to the Court explaining why you don’t like the Settlements. | January 15, 2020 |
| GO TO HEARING | Ask to speak in Court about your opinion of the Settlements. | January 15, 2020 |
| DO NOTHING | You won’t get a payment and will give up your rights to sue the Cephalon, Mylan and Ranbaxy Defendants about the claims in this case. | |
How do I get a payment?
To be eligible to receive a payment if the Court approves the Settlements,
you must complete and submit a valid Claim Form by January 15, 2020.
No one is claiming that Provigil® or Modafinil is unsafe or ineffective.
Important Dates
February 26, 2020, at 10:00 a.m.
December 6, 2019
January 15, 2020
January 15, 2020